Ratings by William Blair
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Sami Corwin | Ultragenyx Pharma | RARE | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
25.81 (15.30) |
-40.72% | Details |
| 9/2/2026 | Sami Corwin | uniQure BV | QURE | New Coverage | Outperform (N/A) |
N/A (N/A) |
47.86 (44.50) |
-7.02% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 3,860 more... | |||||||||
